Literature DB >> 17347857

[Cost of disorders of the brain in Austria in the year 2004].

Johannes Wancata1, Patrick Sobocki, Heinz Katschnig.   

Abstract

OBJECTIVES: The costs of twelve selected neurological, neuro-surgical and psychiatric disorders in Austria in the year 2004 will be presented. The present paper is part of the "Cost of Disorders of the Brain in Europe" study.
METHODS: The data for the present calculations are based on systematic reviews of epidemiological and health-economic studies. For all European countries identical methods were applied. All economic data were transformed to Euros for Austria in the year 2004 ("Purchasing Power Parity adjusted").
RESULTS: The highest costs per case per disorder were caused by brain tumors (49,800 Euro) and multiple sclerosis (30,500 Euro). One-year-prevalence estimates (Austrian population 8.1 million) were highest for anxiety disorders (848,000 cases), followed by migraine (537,000 cases) and affective disorders (479,000 cases). The total costs (i.e. for all cases of a specific disorder in Austria) were highest for affective disorders and addiction (alcohol and illegal drugs). The total cost of all included disorders (addiction, affective disorders, anxiety disorders, brain tumours, dementia, epilepsy, migraine, multiple sclerosis, Parkinson's disease, psychotic disorders, stroke and brain trauma) was estimated at 8.8 billion Euros for Austria in the year 2004. Direct health care cost amounted to Euros 3.2 billion (37% of total cost), direct non-medical cost totalled Euros 1.5 billion (17%), and indirect cost Euros 4.1 billion (47%). DISCUSSION: Even when considering that such estimates based on international studies have methodological limitations, the total cost of the twelve included disorders is considerable. The total cost of these twelve disorders constitutes 4% of the gross national product of Austria. Taken together, these disorders cost each Austrian citizen Euros 1 090 per year.

Entities:  

Mesh:

Year:  2007        PMID: 17347857     DOI: 10.1007/s00508-006-0725-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  28 in total

Review 1.  Economic evidence in multiple sclerosis: a review.

Authors:  Gisela Kobelt
Journal:  Eur J Health Econ       Date:  2004-10

Review 2.  Economic evidence in psychotic disorders: a review.

Authors:  Mickael Löthgren
Journal:  Eur J Health Econ       Date:  2004-10

Review 3.  Economic evidence in affective disorders: a review.

Authors:  Mickael Löthgren
Journal:  Eur J Health Econ       Date:  2004-10

4.  Economic evidence in brain tumour: a review.

Authors:  Mattias Ekman
Journal:  Eur J Health Econ       Date:  2004-10

Review 5.  The epidemiology of epilepsy in Europe - a systematic review.

Authors:  L Forsgren; E Beghi; A Oun; M Sillanpää
Journal:  Eur J Neurol       Date:  2005-04       Impact factor: 6.089

Review 6.  Prevalence of dementia in the elderly in Europe.

Authors:  C Berr; J Wancata; K Ritchie
Journal:  Eur Neuropsychopharmacol       Date:  2005-08       Impact factor: 4.600

Review 7.  Stroke incidence and prevalence in Europe: a review of available data.

Authors:  T Truelsen; B Piechowski-Jóźwiak; R Bonita; C Mathers; J Bogousslavsky; G Boysen
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

8.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

9.  Recognition of psychiatric disorders in nonpsychiatric hospital wards.

Authors:  J Wancata; J Windhaber; M Bach; U Meise
Journal:  J Psychosom Res       Date:  2000-02       Impact factor: 3.006

10.  [The regional budget for mental health care: a new approach to combine inpatient and outpatient care].

Authors:  Christiane Roick; Arno Deister; Dirk Zeichner; Thomas Birker; Hans-Helmut König; Matthias C Angermeyer
Journal:  Psychiatr Prax       Date:  2005-05
View more
  7 in total

1.  [Counselling customers with psychotropic vs. cardiovascular prescriptions: a survey among Austrian community pharmacists].

Authors:  Gisela Hagmair; Michaela Amering; Gerda Kaiser; Heinz Katschnig
Journal:  Neuropsychiatr       Date:  2014-09-09

2.  [Referral success to psychotherapy of patients with personality disorders - therapeutic consequences].

Authors:  Henriette Löffler-Stastka; Sophie Frantal; Victor Blüml; Elisabeth Jandl-Jager
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

Review 3.  Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis.

Authors:  Alexander Konnopka; Hannah König
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

4.  [Implementation of thrombolysis in acute stroke--10-year results of the Innsbruck stroke registry].

Authors:  Benjamin Matosević; Alexandra Zangerle; Martin Furtner; Michael Knoflach; Philipp Werner; Barbara Prantl; Georg Wille; Arne Illmer; Artur Mair; Michael Spiegel; Christoph Schmidauer; Martin Sojer; Armin Muigg; Johann Willeit; Stefan Kiechl
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  [Evaluation of therapy outcome on a psychiatric admission ward. Background, methods and first results of a project on quality management].

Authors:  Anja Wilkening; Michael Zeschky; Marc Ziegenbein; Hans Pfefferer-Wolf; Elke Harms; Gudrun Lübbe; Renate Bläsing; Matthias Albert; Wielant Machleidt; Iris Tatjana Calliess
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  Prevalence of mental diseases in Austria : Systematic review of the published evidence.

Authors:  Agata Łaszewska; August Österle; Johannes Wancata; Judit Simon
Journal:  Wien Klin Wochenschr       Date:  2018-01-24       Impact factor: 1.704

7.  The excess economic burden of mental disorders: findings from a cross-sectional prevalence survey in Austria.

Authors:  Agata Łaszewska; Johannes Wancata; Rebecca Jahn; Judit Simon
Journal:  Eur J Health Econ       Date:  2020-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.